According to the new market research report “Single cell Analysis Market by Product (Consumables and Instruments), Cell Type (Human and Animal), Technique (Flow Cytometry, NGS, PCR, and Mass Spectrometry), Application (Cancer, Neurology, NIPD, IVF, and CTCs), End User — Global Forecast”, published by MarketsandMarkets™, The single cell analysis market is expected to reach $ 3.59 Billion, at a CAGR of 16.5%

Browse 107 market data tables and 42 figures spread through 175 pages and in-depth TOC on “Single-cell Analysis Market. The single-cell analysis market is consolidated in nature due to the presence of a few large players.

Single cell analysis market: The objectives for this study are as follows

• To define, describe, and forecast the market based on products, cell type, technique, application, end user, and region.
• To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
• To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the market
• To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
• To forecast the size of market segments with respect to four regions, namely, North America, Europe, Asia, and the Rest of the World (Row)

The research report segments the market into product, cell type, technique, application, end user, and regions.

Read a Press Release on "single cell analysis market"

https://www.marketsandmarkets.com/PressReleases/single-cell-analysis.asp

Flow cytometry to have the largest market share in 2017

On the basis of technique, the single cell analysis market is segmented into flow cytometry, NGS, PCR, microscopy, mass spectrometry, and other techniques (including single-molecule fluorescence in situ hybridization, micromanipulation, and automated capillary electrophoresis). In 2017, flow cytometry is expected to dominate the market. Wide usage of flow cytometry in single cell analysis applications is expected to boost the demand for single cell analysis techniques.

North America to dominate the market followed by Europe

On the basis of the region, the single cell analysis market is segmented into North America, Europe, Asia, and RoW. In 2017, North America accounted for the largest share of the market, followed by Europe. The large share of the North American market is attributed to the factors such as increasing collaborations among prominent players, technological advancements, and expanding biotechnology and pharmaceutical industries. Factors such as increasing incidence of diseases, government support for various research activities, and growing focus on stem cell research and regenerative medicine are expected to fuel the market growth in the European region.

The single cell analysis market is highly competitive with the presence of major players. Merck KGaA (Germany), Becton, Dickinson and Company (U.S.), Promega Corporation (U.S.), Danaher Corporation (U.S.), General Electric Company (U.K.), Thermo Fisher Scientific Inc. (U.S.), Miltenyi Biotec (Germany), Illumina, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Fluidigm Corporation (U.S.), NanoString Technologies, Inc. (U.S.)

Know more about key industry players: 

https://www.marketsandmarkets.com/ResearchInsight/single-cell-analysis-market.asp